TERLING, Va., March 20, 2020 /PRNewswire/ — Aperiomics, a biotechnology company deploying advanced technologies to identify the root causes of infectious disease, announced today it is now offering a test for the novel coronavirus.
Aperiomics’ Xplore-COVID-19™ test is available nationwide today and the company has already begun taking orders for the test. With the ability to process up to 1000 coronavirus tests per week, Aperiomics can provide test results within 48 to 72 hours of receiving a sample. The tests, which can be ordered for patients at a cost of $250 per sample, utilize a PCR technique designed to identify specific genetic markers within the coronavirus using samples obtained via throat swabs. This test utilizes existing sample collection, DNA extraction, and PCR identification technologies.